Rigel Pharmaceuticals, Inc. (RIGL)

Rigel Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	51.69	32.79	24.46	18.89	30.37	22.52
Short-Term Investments	9.42	24.15	33.75	106.08	26.95	75.56
Cash & Short-Term Investments	61.11	56.93	58.21	124.97	57.33	98.08
Cash Growth	-1.98%	-2.19%	-53.42%	117.99%	-41.55%	-23.70%
Receivables	30.58	30.55	40.32	15.47	15.97	10.11
Inventory	8.18	11.78	17.38	6.62	5.64	4.35
Prepaid Expenses	6.59	-	-	7.41	10.05	6.46
Total Current Assets	106.47	99.27	115.9	154.47	88.98	119.01
Property, Plant & Equipment	0.5	1.03	2.79	11.89	20.57	27.87
Other Intangible Assets	27.69	13.88	14.95	-	-	-
Other Long-Term Assets	4.76	3.06	0.64	0.97	0.82	0.7
Total Assets	139.42	117.23	134.28	167.33	110.38	147.57
Accounts Payable	3.82	7.14	22.51	3.8	3.71	4.15
Accrued Expenses	43.68	29.28	31.91	31.75	24.01	21.26
Current Portion of Long-Term Debt	-	10.87	3.94	7.97	-	-
Current Portion of Leases	0.47	0.69	1.13	9.89	8.62	7.27
Current Unearned Revenue	1.36	1.36	1.37	2.6	3.02	25.29
Other Current Liabilities	5	3.93	4.36	7.55	1.49	0.24
Total Current Liabilities	54.31	53.27	65.21	63.55	40.84	58.21
Long-Term Debt	99.74	92.32	81.71	72.64	19.82	9.81
Long-Term Leases	-	0.29	0.97	0.76	10.65	19.23
Long-Term Unearned Revenue	-	-	-	-	-	1.4
Other Long-Term Liabilities	-	-	-	-	5.05	5.1
Total Liabilities	154.06	145.87	147.9	136.95	76.35	93.75
Common Stock	0.02	0.18	0.17	0.17	0.17	0.17
Additional Paid-In Capital	1,390	1,379	1,369	1,354	1,340	1,330
Retained Earnings	-1,404	-1,408	-1,382	-1,324	-1,306	-1,276
Comprehensive Income & Other	0.01	0.01	-0.15	-0.1	-0	0.02
Shareholders' Equity	-14.64	-28.64	-13.62	30.37	34.03	53.82
Total Liabilities & Equity	139.42	117.23	134.28	167.33	110.38	147.57
Total Debt	100.21	104.17	87.75	91.27	39.09	36.31
Net Cash (Debt)	-39.1	-47.23	-29.55	33.7	18.24	61.77
Net Cash Growth	-	-	-	84.77%	-70.47%	-51.95%
Net Cash Per Share	-2.23	-2.71	-1.71	1.98	1.08	3.69
Filing Date Shares Outstanding	17.62	17.54	17.37	17.17	17	16.86
Total Common Shares Outstanding	17.62	17.48	17.34	17.16	16.93	16.8
Working Capital	52.16	46	50.69	90.91	48.14	60.79
Book Value Per Share	-0.83	-1.64	-0.79	1.77	2.01	3.20
Tangible Book Value	-42.32	-42.52	-28.57	30.37	34.03	53.82
Tangible Book Value Per Share	-2.40	-2.43	-1.65	1.77	2.01	3.20
Machinery	-	1.83	9.48	16.04	15.53	14.64
Construction In Progress	-	-	-	0.69	0.82	0.56
Leasehold Improvements	-	-	2.11	-	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.